Legal Opinion
AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.
District Court, D. Delaware
Decided January 6, 2023No. 1:21-cv-01286Unknown
1Opinion
INTHEUNITEDSTATESDISTRICTCOURT FORTHEDISTRICTOFDELAWARE AZURITYPHARMACEUTICALS,INC., Plaintiff, CivilAction v. Nos. 21-cv-1286,21-cv-1455 BIONPHARMAINC., Defendant. MEMORANDUMOPINION Goldberg,J.1 January6,2023 These cases comprise what the parties refer to as the “Third Wave” in an ongoing patent infringement dispute between Plaintiff Azurity Pharmaceuticals, Inc. (“Azurity”) and Defendant Bionpharma Inc. (“Bionpharma”). The parties’ dispute revolves around Bionpharma’s generic enalapriloralliquid. TheFirstWaveofthislitigationendedwithajudgmentofnoninfringementfor Bionpharma following a bench…
2Cases cited7 opinions
- CoreStates Bank, N.A. v. Huls America, Inc.Court of Appeals for the Third Circuit · 1999
- In Re Robert Goodman, Vic C. Knauf, Catherine M. Houch and Luca ComaiCourt of Appeals for the Federal Circuit · 1993
- Simpleair, Inc. v. Google LLCCourt of Appeals for the Federal Circuit · 2018
- National American Insurance v. United StatesCourt of Appeals for the Federal Circuit · 2007
- Indivior Inc. v. Dr. Reddy's Laboratories, S.A.Court of Appeals for the Federal Circuit · 2019
2 more not listed; retrieve them via the Exa API.